Biologics Extremities Anika Therapeutics Announces Leadership Transition byJosh SandbergJanuary 8, 2026
Biologics Sports Medicine Top Stories Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update byJosh SandbergJuly 30, 2025
Extremities Top Stories Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics byTim AllenOctober 31, 2024
Sports Medicine Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting byJosh SandbergFebruary 13, 2024
Recon Top Stories Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting byJosh SandbergSeptember 20, 2023
Biologics Sports Medicine Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone byJosh SandbergMay 31, 2023
Financial Top Stories Anika Enters Into Cooperation Agreement with Caligan Partners byJosh SandbergApril 13, 2023
Biologics Extremities Regulatory Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA byJosh SandbergApril 3, 2023
